Left atrial structure and function in atrial fibrillation: ENGAGE AF-TIMI 48.
暂无分享,去创建一个
Deepak K Gupta | S. Solomon | E. Antman | R. Giugliano | E. Braunwald | A. Shah | M. Mercuri | V. Mitrović | D. Gupta | Elaine B. Hoffman | Scott D Solomon | Elliott M Antman | Robert P Giugliano | Eugene Braunwald | Michele Mercuri | Christian T Ruff | C. Ruff | Veselin Mitrovic | Naveen Deenadayalu | Amil M Shah | Laura T Grip | L. Grip | Elaine Hoffman | Indravadan Patel | Minggao Shi | Naveen Deenadayalu | M. Shi | Indravadan Patel
[1] E. Antman,et al. Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation-Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF-TIMI 48). , 2010, American heart journal.
[2] T. Sundt,et al. Ablation of atrial fibrillation: comparison of catheter-based techniques and the Cox-Maze III operation. , 2011, The Annals of thoracic surgery.
[3] Bernard Rosner,et al. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. , 1990, The New England journal of medicine.
[4] Samuel Wann,et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committ , 2006, European heart journal.
[5] Habib Gamra,et al. Distribution and Risk Profile of Paroxysmal, Persistent, and Permanent Atrial Fibrillation in Routine Clinical Practice: Insight From the Real-Life Global Survey Evaluating Patients With Atrial Fibrillation International Registry , 2012, Circulation. Arrhythmia and electrophysiology.
[6] W. Tsai,et al. ASSOCIATION OF DECREASED LEFT ATRIAL STRAIN AND STRAIN RATE WITH STROKE IN CHRONIC ATRIAL FIBRILLATION , 2010 .
[7] Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. , 1994, Archives of internal medicine.
[8] H. Pak,et al. The electroanatomical remodelling of the left atrium is related to CHADS2/CHA2DS2VASc score and events of stroke in patients with atrial fibrillation. , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[9] M. Henein,et al. Disturbed left atrial mechanical function in paroxysmal atrial fibrillation: a speckle tracking study. , 2012, International journal of cardiology.
[10] Massimo Santini,et al. Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: follow-up of the Euro Heart Survey on atrial fibrillation. , 2008, European heart journal.
[11] M. Kawasaki,et al. Left atrial global and regional function in patients with paroxysmal atrial fibrillation has already been impaired before enlargement of left atrium: velocity vector imaging echocardiography study. , 2012, European heart journal cardiovascular Imaging.
[12] Andrea Barbieri,et al. Indexed left atrial volume predicts the recurrence of non-valvular atrial fibrillation after successful cardioversion. , 2011, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.
[13] J. Cuzick,et al. A Wilcoxon-type test for trend. , 1985, Statistics in medicine.
[14] J. Sanderson,et al. Peak early diastolic mitral annulus velocity by tissue Doppler imaging adds independent and incremental prognostic value. , 2003, Journal of the American College of Cardiology.
[15] Youshouzhai Gu. Echo , 1980, The Craft of Poetry.
[16] R B D'Agostino,et al. Left atrial size and the risk of stroke and death. The Framingham Heart Study. , 1995, Circulation.
[17] Silvia G. Priori,et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the European society of cardiology committee for PRAC , 2006 .
[18] Arturo Evangelista,et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. , 2009, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[19] Jeroen J. Bax,et al. Impact of left atrial fibrosis and left atrial size on the outcome of catheter ablation for atrial fibrillation , 2011, Heart.
[20] Richard B Devereux,et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardio , 2005, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[21] Silvia G. Priori,et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text , 2006 .
[22] J. Halperin,et al. Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. Stroke Prevention in Atrial Fibrillation Investigators. , 2000, Journal of the American College of Cardiology.
[23] S. Ernst,et al. Strain rate imaging for functional quantification of the left atrium: atrial deformation predicts the maintenance of sinus rhythm after catheter ablation of atrial fibrillation. , 2008, European heart journal.
[24] 李永军,et al. Atrial Fibrillation , 1999 .
[25] A. Banerjee,et al. Pattern of atrial fibrillation and risk of outcomes: the Loire Valley Atrial Fibrillation Project. , 2012, International journal of cardiology.
[26] C. Ayers,et al. Left atrial structure and function and clinical outcomes in the general population. , 2013, European heart journal.
[27] Comparison of 12 Risk Stratification Schemes to Predict Stroke in Patients With Nonvalvular Atrial Fibrillation , 2008, Stroke.
[28] James B Seward,et al. Left atrial size: physiologic determinants and clinical applications. , 2006, Journal of the American College of Cardiology.
[29] M. Brodsky,et al. Are transthoracic echocardiographic parameters associated with atrial fibrillation recurrence or stroke? Results from the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) study. , 2005, Journal of the American College of Cardiology.
[30] S. Solomon,et al. Effect of Cardiac Resynchronization Therapy on Reverse Remodeling and Relation to Outcome: Multicenter Automatic Defibrillator Implantation Trial: Cardiac Resynchronization Therapy , 2010, Circulation.
[31] Pyotr G. Platonov,et al. Clinical predictors of termination and clinical outcome of catheter ablation for persistent atrial fibrillation. , 2009, Journal of the American College of Cardiology.
[32] J. Seward,et al. Left atrial reservoir function as a potent marker for first atrial fibrillation or flutter in persons > or = 65 years of age. , 2008, The American journal of cardiology.
[33] Echocardiographic predictors of stroke in patients with atrial fibrillation: a prospective study of 1066 patients from 3 clinical trials. , 1998, Archives of internal medicine.
[34] Martha J. Radford,et al. Validation of Clinical Classification Schemes for Predicting Stroke: Results From the National Registry of Atrial Fibrillation , 2001 .
[35] M. Ezekowitz,et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. , 2014, Circulation.
[36] W. Manning,et al. Pulsed Doppler evaluation of atrial mechanical function after electrical cardioversion of atrial fibrillation. , 1989, Journal of the American College of Cardiology.
[37] Timothy Watson,et al. Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited , 2009, The Lancet.
[38] R. Giugliano,et al. Novel Oral Anticoagulants in Atrial Fibrillation: A Meta‐analysis of Large, Randomized, Controlled Trials vs Warfarin , 2013, Clinical cardiology.
[39] N. Schiller,et al. Normal left atrial function determined by 2-dimensional echocardiography. , 1983, The American journal of cardiology.
[40] J. Halperin,et al. Left atrial diameter in nonvalvular atrial fibrillation: An echocardiographic study. Stroke Prevention in Atrial Fibrillation Investigators. , 1999, American heart journal.
[41] J. Seward,et al. Left atrial function: physiology, assessment, and clinical implications. , 2011, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.
[42] Gregory Y H Lip,et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. , 2010, Chest.
[43] Salim Yusuf,et al. Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy. , 2007, Journal of the American College of Cardiology.
[44] D. Richards,et al. Left ventricular mass predicts left atrial appendage thrombus in persistent atrial fibrillation. , 2013, European heart journal cardiovascular Imaging.
[45] G. Lip,et al. Atrial fibrillation , 2012, The Lancet.
[46] Salim Yusuf,et al. Efficacy and safety of dabigatran compared to warfarin in patients with paroxysmal, persistent, and permanent atrial fibrillation: results from the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) study. , 2012, Journal of the American College of Cardiology.